跳至主要内容
临床试验/CTIS2023-507481-43-00
CTIS2023-507481-43-00进行中(未招募)1 期

Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)0 个研究点目标入组 500 人开始时间: 2023年11月10日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Age =18 years, Diagnosis of a solid tumor with planned treatment with paclitaxel-based chemotherapy for any indication and with any dose., Mastery of Dutch language, Able and willing to give written informed consent.

排除标准

  • Prior treatment with a paclitaxel-based regimen;, An indication for paclitaxel in combination with moderately or highly emetogenic chemotherapy that mandates the use of dexamethasone as an anti-emetic medication (e.g., carboplatin AUC>4);, Known hypersensitivity to paclitaxel, carboplatin, cetirizine, or excipients (e.g., benzyl alcohol);, Concomitant use of any systemic corticosteroid for any indication other than paclitaxel premedication;, Women with confirmed and ongoing pregnancy;, Already participating in an exercise trial.

研究者

相似试验